Product Description: Uzansertib (INCB053914) is an orally active, ATP-competitive pan-PIM kinase inhibitor with IC50s of 0.24 nM, 30 nM, 0.12 nM for PIM1, PIM2, PIM3, respectively. Uzansertib has broad anti-proliferative activity against a variety of hematologic tumor cell lines[1].
Applications: Cancer-Kinase/protease
Formula: C26H26F3N5O3
References: [1]Koblish H, et al. Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies. PLoS One. 2018 Jun 21;13(6):e0199108.
CAS Number: 1620012-39-6
Molecular Weight: 513.51
Compound Purity: 99.45
Research Area: Cancer
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: Pim